Furthermore, we tested the SCLC CTC lines for expression of typical CSC markers, such as CD133, ABCG2 and sensitivity to salinomycin, but obtained negative results except for the single expression of CD133 in a CTC line established from a patient with primary resistance to cisplatin (manuscript submitted)14. The gene discussed is PROM1; the disease is small cell lung carcinoma.